The Chief Scientific Officer of this biopharmaceutical company sold 20,000 shares in mid-January 2026, amid the company's stock rising 71% throughout the month.

The chief medical officer at one of the top pharmaceutical companies sold nearly 10,000 shares in late January 2026, but the ...

Alphabet is emerging as a top AI option. Microsoft facilitates many AI models. Taiwan Semiconductor's chips are powering a ...

Netflix's (NFLX +0.37%) share prices have trended downward, for the most part, over the past six months. The company is ...

A Co-CEO of a leading neurotherapeutics developer reported significant insider selling amid a year of standout stock ...

Costco has an evergreen membership model that breeds loyalty and generates sales volume. The market is satisfied that it can continue to report growth despite a challenging environment.

The AI Bubble Narrative Just Got Flipped On Its Head. Here's What Investors Need To Know. According to the latest movement, ...

This actively managed fixed income ETF targets diversified bond exposure and reported a 5.09% annualized yield in its latest filing.

The biggest driver of BigBear.ai's poor financial performance is its reliance on government contracts for the majority of its revenue, as the company noted in its quarterly filing. So, changes in ...

This bioscience company has had promising financials, yet one of its top executives exited her entire direct equity ownership in mid-January 2026.

These two EV stocks are hot topics in the automotive industry, but only one is a buy for risk-tolerant investors.

In 2025, Mastercard paid $11.73 billion in stock buybacks and $2.76 billion on dividends. In its latest quarter, which was the first quarter of fiscal 2026, Visa bought back $3.73 billion in stock and ...